Market Tracker

12/22 7:02pm ET
58.76
Real-Time Quote
 -0.82 / -1.38%
Today’s Change
49.23
Today|||52-Week Range
62.20
+17.40%
Year-to-Date
Achillion Pharma Takeout Less Likely Following Subpar Hep C Drug Results
11:40am / TheStreet.com
Dow 30 Stock Roundup: Chevron Acquires New Zealand Exploration Rights, Merck Announce...
Dec 12 / Zacks.com
NewLink Genetics Surges 3% Following Ebola Contract News
10:32am / Benzinga
Best Dividend Paying Stocks Analysts Like in the Dow
Dec 12 / DividendChannel.com
Could Gilead Sciences, Inc. Be a Top Stock in 2015?
7:48am / MotleyFool.com
Merck Reveals Data from Breast Cancer Study on Keytruda - Analyst Blog
Dec 11 / Zacks.com
Could the Next Generation of Diabetes Treatments Be Found in This Illegal Drug?
Dec 21 / MotleyFool.com
Merck suspends trial of Ebola vaccine
Dec 11 / FT.com
Exciting News: A Game-Changing Shingles Vaccine Could Be On Its Way
Dec 21 / MotleyFool.com
Merck-Cubist Deal On Despite Patent Setback, Shares Fall - Analyst Blog
Dec 10 / Zacks.com
Merck Up on OncoEthix Acquisition Deal, Oncology in Focus - Analyst Blog
Dec 19 / Zacks.com
3 High-Yield Dividend Stocks to Buy in December
Dec 10 / MotleyFool.com
Tetraphase Spikes on Encouraging Data on Antibiotic - Analyst Blog
Dec 19 / Zacks.com
Cubist Shoots Up on $9.5 Billion Buyout Offer from Merck - Analyst Blog
Dec 09 / Zacks.com
Bull of the Day: Seattle Genetics (SGEN) - Bull of the Day
Dec 19 / Zacks.com
Biotech ETFs in Focus on Cubist Takeover Deal - ETF News And Commentary
Dec 09 / Zacks.com
NPS Pharmaceuticals and Shire Up on Takeover Rumors - Analyst Blog
Dec 18 / Zacks.com
Merck's New Oncology Product Positive in Early Study - Analyst Blog
Dec 08 / Zacks.com
2014 Healthcare Stock Report Card: Sobek Tracks His Hits and Misses
Dec 18 / TheStreet.com
Superbug threat drives $9.5bn Merck deal
Dec 08 / FT.com
Options Traders Buy the Pullback in Pharmaceuticals Giant Merck
Dec 18 / TheStreet.com
Merck/Cubist: pony up
Dec 08 / FT.com
Juno Therapeutics vies for cancer treatment lead
Dec 17 / FT.com
Why Shares of Cubist Pharmaceuticals Inc Skyrocketed
Dec 08 / MotleyFool.com
Roche Submitted NDA for Melanoma Combination Drug - Analyst Blog
Dec 16 / Zacks.com
Time to Buy This Dip in Gilead Sciences, Inc. Stock?
Dec 08 / MotleyFool.com
The 3 Most Exceptional CEOs of 2014
Dec 16 / MotleyFool.com
Why Cubist Pharmaceuticals Inc. Shares Soared in After-Hours Trading on Friday
Dec 08 / MotleyFool.com
Twitter's Favorite Biotech and Pharma Stocks
Dec 16 / MotleyFool.com
Cubist move highlights antibiotics appeal
Dec 07 / FT.com
A Shift From Healthcare To Discretionary
Dec 16 / StockTwits
Ebola vaccine shows promise in trials
Nov 26 / FT.com
It's Not the Zombie Apocalypse, but Killer Superbugs Could Be on the Way
Dec 14 / MotleyFool.com